Tellam JT, Lekieffre L, Zhong J, Lynn DJ, Khanna R. Messenger RNA Sequence Rather than Protein Sequence Determines the Level of Self-synthesis and Antigen Presentation of the EBV-encoded Antigen, EBNA1. PLoS Pathogens. 2012 Dec 8(12).
Smith C, Khanna R. A new approach for cellular immunotherapy of nasopharyngeal carcinoma. OncoImmunology 2012 Nov 1(8):1440-1442.
Engwerda C, Good MF. Platelets Kill the Parasite Within. Science. 2012 Dec 338.
Neller MA, Burrows JM, Rist MJ, Miles JJ, Burrows SR High frequency herpesvirus-specific clonotypes in the human T cell repertoire can remain stable over decades with minimal turnover. J Virol. 2012 Oct 17. [Epub ahead of print]
From the CIVD DirectorVaccine research requires a multi-disciplinary strategy which involves expertise in basic and applied immunology, pathogenesis, molecular and structural biology with preclinical and clinical trials methodology.
QIMR Berghofer Medical Research Institute encompasses this varied expertise within a single institution and the CIVD harnesses this to advance the science of vaccine development.
Professor Rajiv Khanna
T +61 7 3362 0385